GB201107068D0 - Prebiotic agent - Google Patents
Prebiotic agentInfo
- Publication number
- GB201107068D0 GB201107068D0 GBGB1107068.7A GB201107068A GB201107068D0 GB 201107068 D0 GB201107068 D0 GB 201107068D0 GB 201107068 A GB201107068 A GB 201107068A GB 201107068 D0 GB201107068 D0 GB 201107068D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prebiotic
- prebiotic agent
- improvement
- gastrointestinal
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
A composition for the improvement of gastrointestinal health and/or for the improvement of a gastrointestinal bacterial population is provided. The composition comprises a prebiotic, is adapted for selective targeting of the prebiotic to the colon and is substantially free from probiotic.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1107068.7A GB201107068D0 (en) | 2011-04-26 | 2011-04-26 | Prebiotic agent |
PCT/GB2012/000380 WO2012146890A1 (en) | 2011-04-26 | 2012-04-25 | Prebiotic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1107068.7A GB201107068D0 (en) | 2011-04-26 | 2011-04-26 | Prebiotic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201107068D0 true GB201107068D0 (en) | 2011-06-08 |
Family
ID=44168637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1107068.7A Ceased GB201107068D0 (en) | 2011-04-26 | 2011-04-26 | Prebiotic agent |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201107068D0 (en) |
WO (1) | WO2012146890A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108403970B (en) * | 2018-05-02 | 2020-10-16 | 福建省农业科学院农业工程技术研究所 | Prebiotic composition and preparation method and application thereof |
WO2021113542A1 (en) * | 2019-12-03 | 2021-06-10 | Animal Microbiome Analytics, Inc. (D/B/A Animalbiome) | System and methods for manipulation of the oral microbiome in mammals |
CN115025116B (en) * | 2022-07-13 | 2023-11-21 | 纽湃腾(北京)医药科技有限公司 | Composition for remarkably improving gastroesophageal reflux and irritable bowel syndrome and application thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19836339B4 (en) * | 1998-08-11 | 2011-12-22 | N.V. Nutricia | carbohydrate mix |
US6172040B1 (en) * | 1999-05-28 | 2001-01-09 | A. Satyanarayan Naidu | Immobilized lactoferrin antimicrobial agents and the use thereof |
US20090022852A1 (en) * | 2002-06-21 | 2009-01-22 | Dnp Canada Inc. | Liquid Compositions Comprising Non-Digestible Oligosaccharides and Green Tea Catechins |
EP1600061B1 (en) * | 2004-05-25 | 2010-05-12 | Cognis IP Management GmbH | Oral and/or topical compositions |
US8263141B2 (en) * | 2007-07-30 | 2012-09-11 | Mediglobe Ltd. | Tablet with remedial composition and methods for treating medical disorders and ailments |
IL193129A (en) * | 2007-07-30 | 2013-11-28 | Danielkatz | Composition for the treatment of disorders and ailments of the gastrointestinal tract |
US20090060942A1 (en) * | 2007-08-31 | 2009-03-05 | O'mara Ann Marie | Detoxification Composition and Method of Detoxifying the Body |
CA2762665A1 (en) * | 2009-05-19 | 2010-11-25 | Unilever Plc | A prebiotic composition comprising thearubigin |
GB0918722D0 (en) * | 2009-10-26 | 2009-12-09 | Univ Birmingham | Anti cancer agent |
-
2011
- 2011-04-26 GB GBGB1107068.7A patent/GB201107068D0/en not_active Ceased
-
2012
- 2012-04-25 WO PCT/GB2012/000380 patent/WO2012146890A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012146890A1 (en) | 2012-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX345762B (en) | Anti-infective compounds. | |
TW201611725A (en) | Pest control agent | |
MY178142A (en) | Anti-phf-tau antibodies and their uses | |
PH12014501273A1 (en) | Intranasal dexmedetomidine compositions and methods of use thereof | |
MX2011014019A (en) | Diazahomoadamantane derivatives and methods of use thereof. | |
PL2721045T3 (en) | Compositions, methods of synthesis and use of carbohydrate targeted agents | |
MX2013002784A (en) | Fused heteroaryls and their uses. | |
MY161868A (en) | Anti-bv8 antibodies and uses thereof | |
EA201290623A1 (en) | Lactobacilli with antioxidant action | |
GB2482817A (en) | Novel use | |
IN2013MN02414A (en) | ||
TN2014000136A1 (en) | Selective androgen receptor modulators | |
EP2576575A4 (en) | Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof | |
GB201107068D0 (en) | Prebiotic agent | |
MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
EP2757150A4 (en) | New bacillus subtilis subsp. natto and natto produced using same | |
FI20096400A0 (en) | Use of blood group status I | |
IN2015DN02818A (en) | ||
SG194235A1 (en) | Methods of predicting the development of complement-mediated disease | |
MX2013008559A (en) | Leptin derivatives. | |
UA102047C2 (en) | USE OF STRAIN OF RELIC BACTERIA BACILLUS sp. F AS HEPATOPROTECTOR AND ANTIOXIDANT | |
UA56040U (en) | 1,3-dimethyl-7-n-chlorobenzene-8-n-bromobenzylidene hydrazinoxanthine exhibiting diuretic and anti-oxidant action | |
UA70698U (en) | Use of 2-methyl-3-phenylaminomethylquinolin-4-one as antihypoxic, actoprotective and antialcoholic substance | |
UA56041U (en) | 1,3-dimethyl-7-n-methylbenzene-8-n-hydrazinoxanthine exhibiting diuretic action | |
UA94339C2 (en) | use of Corvitine as frigoprotective agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |